Assertio Holdings Engages in Healthcare Virtual Summit 2024
Assertio Holdings Engages in Healthcare Virtual Summit 2024
LAKE FOREST, Ill. — Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a forward-thinking pharmaceutical company, is excited to announce that its Chief Executive Officer, Brendan O’Grady, will be part of the Maxim Group 2024 Healthcare Virtual Summit. O'Grady will engage in an insightful fireside chat discussion, moderated by Naz Rahman, a research analyst with Maxim Group.
Event Details
The engaging conversation is scheduled for Tuesday, October 15, 2024, at 1:00 PM Eastern Time. This event represents a remarkable opportunity for investors and industry professionals alike, as it offers a platform to delve deeper into the strategic initiatives and innovative solutions that Assertio is dedicated to providing.
Event Participation
This summit is designed to connect healthcare thought leaders and innovators, allowing them to share insights and discuss trends shaping the future of pharmaceuticals. Assertio, known for its commitment to developing differentiated products, is eager to contribute to this important discussion.
About Assertio
Assertio is not just a pharmaceutical company; it is a hub for commercial excellence in the healthcare industry. Assertio has developed a robust portfolio through thoughtful acquisitions and partnerships, focusing on approved products that meet the diverse needs of patients. Their strategic marketing efforts blend a dedicated sales force with innovative non-personal promotion techniques, ensuring the reach and effectiveness of their product offerings.
Commercial Capabilities
With strong market access strategies, Assertio engages in effective payor contracting and sophisticated distribution channels. This multi-faceted approach allows the company to effectively connect with healthcare providers and patients, ensuring that vital medications are accessible to those who need them most.
Investor Information
Stakeholders and interested parties can gain additional insights into Assertio’s strategic direction and offerings by participating in this engaging summit. For further inquiries about the company, investors are encouraged to reach out directly.
Contact for Investors
Matt Kreps, Managing Director
Darrow Associates
M: 214-597-8200
Email: mkreps@darrowir.com
Frequently Asked Questions
What is the purpose of the Maxim Group Healthcare Virtual Summit?
The summit aims to connect innovators, industry leaders, and investors in the healthcare space to discuss advancements and trends in the pharmaceutical industry.
Who will be representing Assertio at the summit?
Brendan O’Grady, the Chief Executive Officer of Assertio Holdings, will be participating in the fireside chat during the event.
What are Assertio's main commercial capabilities?
Assertio excels in marketing and distribution with a mix of personal sales and non-personal promotion, alongside effective payor contracting.
How can investors learn more about Assertio's offerings?
Investors can engage with the company during the summit and reach out directly for further information.
Where can I find more information about Assertio?
To learn more about Assertio's products and corporate strategy, visit their official website at www.assertiotx.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Flashpoint Announces Sponsorship of OSINT Conference at Citadel
- Global Diagnostic Testing Market Expected to Reach $272.98 Billion
- Blain’s Farm & Fleet Opens Toyland 2024 for Holiday Fun
- Seattle Hotel Workers Demand Transparency in Resort Fees
- Exploring the Strategic Advantages of Thames Ventures Merger
- TriCelX, Inc. Launches Innovative Flagship Clinic for All
- Alliance Witan PLC's Shareholder Management Insights 2024
- Empowering Future Game Developers with Scholarships and Support
- Understanding the Financial Performance of Quest Insurance Group
- Fan-Inspired Design Takes Center Stage in Austin Race
Recent Articles
- Tissue Diagnostics Market Set for Accelerated Growth Ahead
- Transforming Manufacturing: Hurco's AI Innovations Unveiled
- Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events
- InnovAge's Commitment to Transforming Elderly Care Practices
- Exploring Growth Opportunities in Customer Experience Management
- Pottery Barn Launches Festive Collection for Polar Express 20th Anniversary
- Aligos Therapeutics Announces New Employee Stock Options Grants
- Paltalk Achieves Legal Victory with Final Judgment Against Cisco
- Lattice Semiconductor Names New Interim CFO to Drive Growth
- New Insights from Disc Medicine on Chronic Kidney Disease Treatment
- Exciting Updates on DISC-0974 for Chronic Kidney Disease Patients
- Sylvamo's Upcoming Earnings Release and Webcast Details
- Alignment Healthcare Achieves High Star Ratings for 2025 Plans
- Inspirational Lineup Announced for Crypto Content Creation
- InnovAge Announces Upcoming Innovations for Elderly Care
- MaxCyte Announces Upcoming Financial Release and Call Details
- Unity Software to Present Q3 2024 Financial Results Online
- Baird Medical Reports Strong Growth in Preliminary Financials
- Auron Therapeutics Set to Shine at Upcoming Medical Retreat
- European DataWarehouse Celebrates Excellence in Data Quality
- EveryMatrix Acquires Majority Stake in Fantasma Games
- Assertio Holdings Joins 2024 Healthcare Virtual Summit
- Lazard Readies for Financial Results Announcement This Fall
- Compassionate Support for Hurricane Victims in Storage Needs
- Growth Forecast for Enteral Feeding Devices Market Until 2031
- WisdomTree Plans Q3 Results Conference Call for Investors
- Zaxby's Expands into Maryland with New Chicken Locations
- Exploring Growth Opportunities at Indigenomics on BAY STREET
- ESET Canada Strengthens Ties with Calgary Flames for Three More Years
- Bladex Announces Third Quarter 2024 Earnings Call Details
- Similarweb Shines as Alternative Data Provider of the Year
- Impact of Lithium Mine Closure on Battery Metal Prices
- Empowering Girls: Game Changers Initiative by BBBSA
- Rio Tinto's Jadar Project Thrives Despite Parliamentary Debate
- The Home Depot Foundation Boosts Hurricane Relief Commitment
- Wells Fargo's Q3 Profit Decline Amid Squeezed Interest Income
- CoreWeave Secures $650 Million Credit Facility to Propel Growth
- Evolent Health's 2024 Financial Update and Investor Events
- Understanding Medicare Enrollment Scams and How to Avoid Them
- Wells Fargo Adjusts Flywire Rating Amid Market Concerns
- Bank7 Corp. Reports Impressive Q3 2024 Earnings Results
- Toronto-Dominion Bank Faces Challenges Amid RBC Downgrade
- Scholar Rock Gains Momentum Following Strong Clinical Trial Results
- A. O. Smith Adjusts Earnings Expectations Amid Market Changes
- Tyra Biosciences Innovations At The EORTC-NCI-AACR Symposium
- Tesla's Robotaxi Showcase: Maintain Hold Rating Insights
- Mark Dorsey Appointed as Chief Revenue Officer at Appian
- Wynn Resorts Shows Growth Potential with Al Marjan Project
- ThinkCERCA Accelerates Education Tech with $250,000 Win
- Piper Sandler Raises AMD Price Target to $200 Amid Growth